Sugar Maple Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Sugar Maple Asset Management, LLC
- $129 Million
- Q4 2025
A detailed history of Sugar Maple Asset Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Sugar Maple Asset Management, LLC holds 110,000 shares of IOVA stock, worth $271,700. This represents 0.21% of its overall portfolio holdings.
Number of Shares
110,000Holding current value
$271,700% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
289Shares Held
219MCall Options Held
2.41MPut Options Held
1.7M-
Mhr Fund Management LLC New York, NY29MShares$71.5 Million10.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$59.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$52.4 Million0.0% of portfolio
-
State Street Corp Boston, MA13.3MShares$32.9 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA10.5MShares$26 Million1.15% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $390M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...